About this trial
Ischemic conditioning (IC) is a promising therapy that can mimic the physiological effects of physical exercise. IC consists of using a cuff to measure blood pressure and calibrate 200 mmHg on the upper or lower limb. Thus, at alternating intervals of 5 minutes, ischemia or reperfusion occurs, depending on whether the cuff is inflated or deflated. IC induces changes in spinal cord excitability for the last reflex reactions of recruited motoneurons with improved balance control in healthy young people and improved learning in the elderly. The objective of the present study is to evaluate the chronic effect of IC on the motor function and cognitive performance of patients with Parkinson's disease. Furthermore, the investigators will evaluate secondary outcomes such as mobility, quality of life, and immunological responses.
Eligibility criteria
Qualifiers
PD patients aged 40 years or older;
Diagnosis of PD without cognitive complaints or with complaints, but without impact on daily activities;
Disqualifiers
Patients with uncontrolled diabetes mellitus or peripheral neuropathy;
Uncontrolled arterial hypertension (BP>160/100mmHg);
Uncontrolled diabetes (Fasting glucose > 250mg/dl, peripheral retinopathy or diabetic ketoacidosis);
Uncontrolled dyslipidemia (total chol > 220mg/dL);
Trial design
Treatments tested in this trial
- Ischemic conditioning group
- Sham group
Treatment groups
Locations
Sponsors and collaborators
Hospital Israelita Albert Einstein
Lead sponsor
Unifesp Escola Paulista de Medicina
Collaborator